Companies Scramble To Get Patent On Marijuana



In October, the U.S. government issued Axim Biotechnologies a patent for a cannabis-based medication designed to specifically target irritable bowel syndrome.

Be the first to comment

Leave a Reply

Your email address will not be published.


*